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Introduction
Depression is a prevalent psychiatric dysfunction that is 
identified with depressed mood, loss of interest or pleasure, 
feelings of guilt or low value, disturbance of sleep and 
appetite, low power and poor centralization, interfering 
with normal function, and often has problems at work, 
community and family. According to the World Health 
Organization (WHO), depression will become the second 
factor contributing to disability of disease in 2020 (1,2). It 
has been shown that various factors such as psychological-
social, genetic and biological factors play a role as causing 
depression. However, one of the major biological causes of 
depression is reduction in the amount of neurotransmitters 
such as serotonin (5-hydroxytriptamine, 5HT), dopamine 
(DA) and noradrenalin (NA) (3,4). 
Nowadays, various pharmacological treatments, including 
tricyclic antidepressants, selective serotonin reuptake 
inhibitors, monoamine oxidase inhibitors and selective 
serotonin-noradrenalin inhibitors are used (5). These drugs 
exert their effects by increasing the amount of brain mono-
amines (6). However, most of these drugs cause some 
unwanted symptoms and their mechanism of action has 
not been very satisfactory. Therefore, it is essential to search 
new, strong and especially healthy drugs (7). 
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Introduction: Passiflora incarnata (PI) is one of the commonest herbal anti-anxiety and sedative 
agents. The aim of the present study was to investigate the antidepressant effect of hydroalcoholic 
extract of PI in forced swim test (FST) and tail suspension test (TST) in male mice.
Methods: In this experimental study, 48 male mice were randomly divided into 6 groups of 8: 
Negative and positive control groups received normal saline (10 ml/kg), fluoxetine (20 mg/kg) and 
imipramine (30 mg/kg), respectively and treatment groups received extracts of PI (200, 400 and 800 
mg/kg). Immobility, swimming and climbing behaviors were recorded during 6-min. 
Results: All doses of PI extract compared to control group significantly reduced the duration of 
immobility time in both of two tests (p<0.001). Also, these extracts increased swimming time 
(p<0.001) without significant change of climbing time.
Conclusion: PI has considerable antidepressant-like effect in animal models of depression. However, 
further studies are needed to determine its exact mechanism of action.
A R T I C L E  I N F O
Keywords:
Passiflora incarnata
Hydroalcoholic extract
Forced swim test
Tail suspension test
Mice
Article History:
Received: 21 February 2014
Accepted: 14 April 2014
ePublished: 1 June 2014
Article Type:
Original Article
A B S T R A C T
Jafarpoor N et al.
Journal of HerbMed Pharmacology, Volume 3, Number 1, June 2014 http://www.herbmedpharmacol.com 42
Passionflower is an herbaceous plant with the scientific 
name of Passiflora incarnate (PI). This plant is a perennial 
herb and has a climbing or trailing stem with alternate 
and lobed leaves. It shows individual blue flowers. Fruits 
are green and after ripening will be orange. This plant is 
cultivated in different countries and even in northern Iran 
as an ornamental plant. It has been shown that passion 
flower has a number of compounds including flavonoids, 
the cyanogenic glycosides, indole alkaloids and other 
alkaloids, such as the passiflorine, harmaline, harmine 
and harmalol in its building. Studies have reported that 
passion flower has different effects such as analgesic, 
anticonvulsant, anti-bacterial, anti-anxiety, hypnotics, 
sedatives, etc. (8,9). Considering that no study already has 
been done on anti- depression effects of passionflower; the 
purpose of the present study was to investigate the effect 
of passionflower hydroalcoholic extract in the forced swim 
test and the tail suspension test as two animal models of 
depression in male mice.
Materials and Methods 
In this experimental study, 48 male albino mice NMRI 
(weighing 20 to 30 g) were randomly divided into 6 groups 
of 8. Animals were housed in cages of 5 at 22 ± 1 oC in a 
12-h light/dark cycle, and had free access to water and 
food. Each animal was evaluated only once. Animals were 
transferred laboratory to adapt to the lab environment for 
48 hours before testing. All procedures in this study were 
performed in accordance with the NIH Guide for the Care 
and Use of Laboratory Animals. The experimental protocol 
was approved by the Committee on Animal Research; 
Urmia Medical University.
In this study, fluoxetine hydrochloride (Arya Pharmaceutical 
Co., Iran), imipramine hydrochloride (medicine Pars 
Co., Iran) and PI hydroalcoholic extract (Iran Darouk 
Pharmaceutical Co., Iran); all in powder form were used. 
All drugs and extracts were dissolved in normal saline (NS 
0.9%) and administered intraperitoneally (i.p.) at a constant 
volume of 10 ml/kg.
The negative control group or normal saline group received 
normal saline (10 ml/kg, i.p). Positive control groups 
received fluoxetine (20 ml/kg, i.p) and imipramine (30 ml/
kg, i.p). The other three groups were treated with different 
doses of 200, 400 and 800 mg/kg of PI hydroalcoholic 
extract, respectively.
In the forced swim test (FST), mice were separately placed 
in cylindrical containers, with dimensions of 8 × 12 × 25 
cm, containing water at 25 °C, 30 min after injection of 
extracts or drugs. Each mouse was judged to be immobile 
when it ceased struggling and remained floating motionless 
in the water, making only those movements necessary to 
keep its head above water. The whole test was 6 minutes, 2 
minutes to match the animal to the environment, and next 
4 minutes were recorded as immobility time, swimming 
time and climbing time in seconds by the chronometer (10). 
In the forced swim test, immobility time and its reduction 
were recorded as depression and anti-depression effect, 
respectively. Swimming is equivalent to active movements 
of the hands and feet of the animal and the rotation around 
the cylinder, and climbing is also equivalent to active 
movements of animal hands on the walls of the cylinder (11).
Tail suspension test (TST) is also an additional common 
animal model for estimating depression in animals. In this 
test, the metal legs with a height of 70 cm were used and a 
string of 50 cm was longitudinally stretched between two 
metal legs. Mice tail was closed by a clause and the animal 
was hung on the tail. In this part also the test began with 
a rush mice, 30 min after drug or extract administration. 
The immobility time was considered when the animal 
was completely immobile, disabled and had no response. 
The period of this test, the same as the previous method, 
was 6 minutes, again first 2 minutes to match the animal 
to the environment and next 4 minutes were recorded as 
immobility time in seconds by the chronometer. In both 
tests, all the samples were recorded by a person who did not 
know which sample belonged to which group. The test was 
performed 30 min after drug or extract injection (12).
In this study, one-way analysis of variance (one-way 
ANOVA) and Tukey test were used. The statistical analysis 
was performed using SPSS, version 19, and in each case the 
p<0.05 was considered as the significance level.
Results
The results of this study showed that normal saline injection 
caused no significant change in the immobility, swimming 
and climbing times compared with the situation before 
the injection. Therefore, all experimental groups were 
compared with saline as a negative control.
Results showed that all three doses of hydroalcoholic 
extract of PI in the forced swim test (128.83±9.34, 
114.14±6.64 and 99.73±9.15 respectively; p<0.001) and tail 
suspension test (120.03±10.49, 97.98± 8.51 and 76.72± 6.05 
respectively; p<0.001) significantly reduced the immobility 
time compared with control groups (189.11±7.25 and 
197.55±3.86 respectively) (Figure 1 and 2). 
Fluoxetine and imipramine in comparison with the control 
group significantly decreased the immobility time (73.55± 
7.03 and 23.79±5.36 respectively; p<0.001) (Figure 1). Both 
drugs also reduced immobility time in the tail-supension 
test (128.6± 6.02 and 27.08±3.73 respectively; p<0.001) 
(Figure 2).
Doses of hydroalcoholic extract of passion flower 
(107.67±9.67, 120.84±5.69 and 138.21±10.41 respectively; 
p<0.001) compared with the control group (44.56±6.84) 
significantly increased the swimming time (Figure 1). 
Climbing behavior did not increase significantly by 
any of the doses of extract (Figure 1). In this section, 
fluoxetine increased swimming behavior compared to the 
control group (153.85±11.3; p<0.001), without significant 
change of climbing behavior (p>0.05) (Figure 1). But 
conversely, imipramine increased the climbing behavior 
(105.66±11.39; p=0.000), but was not observed a 
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Figure 1. The effect of different doses of hydroalcoholic extract of Passiflora incarnata (PI; 200, 400, and 800 mg/kg; i.p), fluoxetine (20 
mg/kg; i.p), and imipramine (30 mg/kg; i.p) on immobility, swimming and climbing in the forced swimming test in mice. The data are shown 
as Mean±SEM; ***significant at p<0.05 compared with control group.
Figure 2. The effect of different doses of hydroalcoholic extract of Passiflora incarnata (PI; 200, 400, and 800 mg/kg; i.p), fluoxetine (20 
mg/kg; i.p), and imipramine (30 mg/kg; i.p) on immobility time in the tail-supension test in male mice. The data are shown as Mean±SEM; 
***significant at p<0.05 comparison with control group.
significant increase in the swimming behavior (p<0.05) 
(Figure 1).
Discussion
In this study, the antidepression effects of hydroalcoholic 
extract of PI were studied in mice by using FST and TST 
as an animal models of depression. Forced swim test is one 
of the most commonly used animal models for estimating 
the anti-depression effects of chemical and herbal agents 
in mice and rats. This model is sensitive to the effects 
of all medications and extracts (13). Tail suspension 
test is also among other animal models to estimate the 
effect of antidepressants. This test unlike the FST, does 
not lead to a stress and reduction in body temperature 
that usually is caused by the forced swim test (14). The 
results of this study demonstrated that different doses of 
PI extract compared with the control group decreased 
immobility time in both the FST and TST. On the other 
hand, the extract increased swimming time, but climbing 
behavior did not significantly enhance. The results of the 
present in accordance with other findings. The effects of 
fluoxetine and imipramine were demonstrated in the FST 
and TST (15,16). In other words, previous studies have 
reported that the drugs with serotonergic mechanism 
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(e.g. fluoxetine) reduce the time immobility, increase 
the swimming time, without any significant change of 
climbing time. On the hand, drugs with noradrenergic 
mechanisms reduce the immobility time, increase the 
climbing time and the changes are not significant in the 
swimming time (17,18). Although the exact mechanism 
of antidepression effect of PI has not been established, 
but consistent with other findings and conclusions of this 
study, the effects of the PI extract is similar to fluoxetine. 
In support of these findings, studies have shown that PI 
has several compounds in its building, but among them, 
the beta-carboline alkaloids such as harmaline, harmine 
and harmalol have anti-depression properties (19). 
In this regard, it has been shown that these alkaloids 
are irreversible monoamine oxidase-A inhibitors (20). 
There are two isoforms (MAO-A and MAO-B) for the 
monoamine oxidase enzyme. MAO-A inhibits reduce the 
degeneration of adrenaline and serotonin in the brain, but 
MAO-B inhibits reduce the degeneration of dopamine. 
Thus, MAO-A inhibitors are used in depression and 
MAO-B inhibitors are applied in diseases such as 
Parkinson’s (21,22). Therefore, inhibition of MAO-A 
by the passion flower alkaloids increases the amount of 
adrenaline and serotonin in the brain of animals treated 
with it (19). In agreement with these findings, it has been 
shown that the harmine binds to MAO-A and many 
cell surface receptors, including the serotonin receptor 
2A (5HT2A) that are involved in pharmacotherapy for 
depression (23-25). On the other hand, other studies 
have reported that harman and other beta-carbolines 
can cause a wide range of antagonistic effects against 
benzodiazepines via binding to inverse agonist sites of 
GABA-A receptors. Unlike benzodiazepines that bind to 
benzodiazepine receptor sites (BZ1 and BZ2) and reduce 
norepinephrine and serotonin release, beta-carbolines 
bind to inverse agonist sites and increase catecholamines 
and serotonin release (26,27). In support of these findings, 
flumazenil (antagonist of benzodiazepine receptors and 
an inverse agonist) antagonized the beta-carboline effect 
(28). Thus, it seems that serotonergic and GABAergic 
systems involved in PI antidepressant effects.
Conclusion
According to the results of this study, PI has considerable 
antidepressant-like effect in animal models of depression. 
However, concomitant use of serotonin and GABA 
antagonists along with the PI extract, and isolation of each 
of its components and evaluation of them on depression is 
recommended in order to determine the exact mechanism 
of PI antidepression effects.
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